首页 | 本学科首页   官方微博 | 高级检索  
检索        


Oxycodon,Piritramid und Tramadol zur postoperativen Schmerztherapie
Authors:Email author" target="_blank">I?MuraskaiteEmail author  S?Koscielny  M?Komann  C?Weinmann  W?Mei?ner
Institution:1.Klinik für An?sthesiologie und Intensivmedizin,Universit?tsklinikum Jena,Jena,Deutschland;2.Klinik und Poliklinik für HNO-Heilkunde,Universit?tsklinikum Jena,Jena,Deutschland
Abstract:

Background

In the context of improving perioperative pain management and shortening hospital stays, potent oral analgesics, such as slow release opioids, are gaining increasingly in importance.

Objective

The aim of this study was to compare the use and effectiveness of different opioids in postoperative pain treatment in Germany.

Materials and methods

Using data from the QUIPS database, the records of 5249 patients were evaluated. The total study population was divided into four groups: group 1 (10?mg oxycodone with or without naloxone 5?mg), group 2 (20?mg oxycodone with or without naloxone 10?mg), group 3 (piritramide) and group 4 (tramadol). Maximum pain intensity, pain-related interference with sleep and respiration, vomiting, postoperative fatigue, desire for more pain treatment and satisfaction with pain management were evaluated.

Results and discussion

The differences in pain intensity were statistically significant between groups. Patients with piritramide reported more pain, more interference with sleep and respiration and more fatigue compared to those from the other groups. In the group with 10?mg oxycodone, the desire for additional pain medication was the lowest. Postoperative vomiting and satisfaction with pain management differed significantly between the four groups. Procedure-specific analysis has shown that differences between sub-groups were also significant following cholecystectomy and total knee arthroplasty.

Conclusions

In summary, our findings suggest that postoperative pain treatment with slow release oral oxycodone does not show disadvantages compared to tramadol or piritramide with regard to pain-related impairments and opioid-induced side effects. This hypothesis needs to be further analyzed in controlled studies.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号